Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Neuroinflammation
• Lipid Mediator Biology

Background:

• Multiple sclerosis (MS) is characterized by unresolved neuroinflammation disrupting cellular homeostasis.
• Specialized pro-resolving lipid mediators (SPMs), derived from omega fatty acids, are crucial for resolving inflammation.
• The functional status and precise role of SPMs in MS remain incompletely understood.

Purpose of the Study:

• To review current data on the role of SPMs in multiple sclerosis.
• To explore the potential of SPMs as biomarkers and therapeutic targets for MS.
• To clarify the mechanisms of SPM action in neuroinflammation.

Main Methods:

• Literature review of existing studies on SPMs and MS.
• Analysis of data on SPM levels in MS patient biofluids.
• Examination of preclinical models investigating SPM effects on neural cells.

Main Results:

• Dysfunction in SPM biosynthesis pathways is linked to altered SPM levels in MS patients.
• Altered SPM levels correlate with increased inflammation and disease severity in MS.
• SPMs show neuroprotective effects on microglia in preclinical MS models, but direct effects on neurons and oligodendrocytes are not yet reported.

Conclusions:

• The role of SPMs in MS is complex and may vary, necessitating further research.
• SPMs hold potential for developing novel biomarkers and alternative therapies for MS.
• Understanding SPM mechanisms could offer pathways to prevent or treat MS and other neurodegenerative diseases.